Search - tctmd.com

Displaying 81 - 100 of 235

Sort: Relevancy | Date

Presentation TVT 2021

Complete 2-year Follow-Up from Evolut Low Risk Trial

Presenter: John Forrest

July 20, 2021

Presentation TVT 2021

Session 1: Tailoring Mitral Valve Repair: MitraClip G4 Review & Evolution of TEER

Presenter: Paul Mahoney

July 20, 2021

Presentation TVT 2021

Remaining Unmet Technical and Clinical Needs in TAVR: Opportunities for Innovation to Improve Clinical Outcomes

Presenter: Azeem Latib

July 20, 2021

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Presenter: Michael Reardon

October 16, 2020

Presentation TCT 2020

Grading FMR Severity: Evolution of the Concept and Evolving Data

Presenter: Paul Grayburn

October 14, 2020

Presentation TCT 2020

TCT 507: We Present a Case Involving TAVI Using a Medtronik Evolut R. On Deployment of the Device, Both Coronaries Were Widely Patent and Position Appeared Good. Within 30 Minutes of Deployment, the Self-Expanding Nature of the Device Caused Obstruction…

Presenter: Matthew Mercieca Balbi

October 14, 2020

Presentation TCT 2020

TCT 473: Reproducibility of Cusp Overlap Technique to Reduce Permanent Pacemaker Implantation With Evolut – The Latin American Experience

Presenter: Hemal Gada

October 14, 2020

Presentation TCT 2020

TCT 087: Redo Transcatheter Aortic Valve Replacement With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the TVT Registry

Presenter: Guilherme Attizzani

October 14, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Presenter: Guilherme F. Attizzani

June 20, 2020

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation TCT 2019

The (R)evolution of Image-based FFR – Introducing the CathWorks FFRangio System

Presenter: Bruce Samuels

September 27, 2019

Presentation TCT 2019

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

Presenter: Robert Califf

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Presenter: Lori Ashby

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Presentation TCT 2019

Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept

Presenter: William Maisel

September 26, 2019

Presentation TCT 2019

COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward

Presenter: Elizabeth Perpetua

September 25, 2019

Presentation TCT 2019

The Technology Evolut™ System: Overview and Performance

Presenter: Michael Caskey

September 25, 2019

Presentation TVT 2019

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Presenter: Mubashir Mumtaz

June 14, 2019

Advertisement

Complete 2-year Follow-Up from Evolut Low Risk Trial

Session 1: Tailoring Mitral Valve Repair: MitraClip G4 Review & Evolution of TEER

Remaining Unmet Technical and Clinical Needs in TAVR: Opportunities for Innovation to Improve Clinical Outcomes

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Grading FMR Severity: Evolution of the Concept and Evolving Data

TCT 507: We Present a Case Involving TAVI Using a Medtronik Evolut R. On Deployment of the Device, Both Coronaries Were Widely Patent and Position Appeared Good. Within 30 Minutes of Deployment, the Self-Expanding Nature of the Device Caused Obstruction…

TCT 473: Reproducibility of Cusp Overlap Technique to Reduce Permanent Pacemaker Implantation With Evolut – The Latin American Experience

TCT 087: Redo Transcatheter Aortic Valve Replacement With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the TVT Registry

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Show me the Data: Key Clinical Trials of 2019

The (R)evolution of Image-based FFR – Introducing the CathWorks FFRangio System

Keynote Lecture: A Vision for an Evolving Regulatory and Healthcare System

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Keynote Lecture: New Technology Assessment and Reimbursement Synergy — Forward Strides

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Keynote Lecture: FDA/CDRH — The Year in Review, Focus on CDRH’s Total Product Life Cycle Concept

COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward

The Technology Evolut™ System: Overview and Performance

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content